102 related articles for article (PubMed ID: 18972259)
1. The aminothiol redox status in haemodialysis patients does not improve with folate therapy.
Apeland T; Kristensen O; Mansoor MA
Scand J Clin Lab Invest; 2009; 69(2):265-71. PubMed ID: 18972259
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins.
Apeland T; Frøyland ES; Kristensen O; Strandjord RE; Mansoor MA
Epilepsy Res; 2008 Nov; 82(1):1-6. PubMed ID: 18644700
[TBL] [Abstract][Full Text] [Related]
3. Homocysteinemia correlates with plasma thiol redox status in patients with end-stage renal disease.
Palleschi S; De Angelis S; Rossi B; Diana L; Papa V; Severini G; Splendiani G
Nephron Clin Pract; 2008; 108(2):c106-12. PubMed ID: 18212512
[TBL] [Abstract][Full Text] [Related]
4. Kidney donors and kidney transplants have abnormal aminothiol redox status, and are at increased risk of oxidative stress and reduced redox buffer capacity.
Apeland T; Holdaas H; Mansoor MA
Clin Biochem; 2014 Apr; 47(6):378-82. PubMed ID: 24530370
[TBL] [Abstract][Full Text] [Related]
5. Alteration in the redox state of plasma in heart-transplant patients with moderate hyperhomocysteinemia.
Di Giuseppe D; Di Simplicio P; Capecchi PL; Lazzerini PE; Pasini FL
J Lab Clin Med; 2003 Jul; 142(1):21-8. PubMed ID: 12878982
[TBL] [Abstract][Full Text] [Related]
6. Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin.
Campolo J; Caruso R; De Maria R; Parolini M; Oliva F; Roubina E; Cighetti G; Frigerio M; Vitali E; Parodi O
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1024-8. PubMed ID: 18163014
[TBL] [Abstract][Full Text] [Related]
7. Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation.
Stopper H; Treutlein AT; Bahner U; Schupp N; Schmid U; Brink A; Perna A; Heidland A
Nephrol Dial Transplant; 2008 Oct; 23(10):3272-9. PubMed ID: 18469307
[TBL] [Abstract][Full Text] [Related]
8. The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols.
Di Giuseppe D; Frosali S; Priora R; Di Simplicio FC; Buonocore G; Cellesi C; Capecchi PL; Pasini FL; Lazzerini PE; Jakubowski H; Di Simplicio P
J Lab Clin Med; 2004 Nov; 144(5):235-45. PubMed ID: 15570241
[TBL] [Abstract][Full Text] [Related]
9. The effect of oral folic acid upon plasma homocysteine, endothelial function and oxidative stress in patients with type 1 diabetes and microalbuminuria.
Wotherspoon F; Laight DW; Turner C; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
Int J Clin Pract; 2008 Apr; 62(4):569-74. PubMed ID: 18248393
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against N-homocysteinylated proteins in patients on long-term haemodialysis.
Undas A; Kolarz M; Kopec G; Glowacki R; Placzkiewicz-Jankowska E; Tracz W
Nephrol Dial Transplant; 2007 Jun; 22(6):1685-9. PubMed ID: 17317712
[TBL] [Abstract][Full Text] [Related]
11. Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense system.
Ueland PM; Mansoor MA; Guttormsen AB; Müller F; Aukrust P; Refsum H; Svardal AM
J Nutr; 1996 Apr; 126(4 Suppl):1281S-4S. PubMed ID: 8642471
[TBL] [Abstract][Full Text] [Related]
12. Plasma aminothiol oxidation in chronic hemodialysis patients.
Himmelfarb J; McMenamin E; McMonagle E
Kidney Int; 2002 Feb; 61(2):705-16. PubMed ID: 11849414
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
[TBL] [Abstract][Full Text] [Related]
14. Effect of folate supplementation on serum homocysteine and plasma total antioxidant capacity in hypercholesterolemic adults under lovastatin treatment: a double-blind randomized controlled clinical trial.
Shidfar F; Homayounfar R; Fereshtehnejad SM; Kalani A
Arch Med Res; 2009 Jul; 40(5):380-6. PubMed ID: 19766902
[TBL] [Abstract][Full Text] [Related]
15. Plasma redox status and premature onset of senile cataract.
Vîrgolici B; Stoian I; Muscurel C; Mărăcine M; Moraru C; Dinu V
Rom J Intern Med; 2007; 45(1):59-65. PubMed ID: 17966444
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological dose of vitamin B12 is as effective as low-dose folinic acid in correcting hyperhomocysteinemia of hemodialysis patients.
Chiu YW; Chang JM; Hwang SJ; Tsai JC; Chen HC
Ren Fail; 2009; 31(4):278-83. PubMed ID: 19462276
[TBL] [Abstract][Full Text] [Related]
17. Modulation of erythrocyte sensitivity to oxidative stress by transient hyperhomocysteinemia in healthy subjects and in patients with coronary artery disease.
Vesentini N; Kusmic C; Battaglia D; Taddei MC; Barsanti L; Parodi O; Palombo C; Paolicchi A; Barsacchi R
Nutr Metab Cardiovasc Dis; 2008 Jul; 18(6):402-7. PubMed ID: 18029159
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
Antoniades C; Antonopoulos AS; Tousoulis D; Marinou K; Stefanadis C
Eur Heart J; 2009 Jan; 30(1):6-15. PubMed ID: 19029125
[TBL] [Abstract][Full Text] [Related]
19. Butyrylcholinesterase activity is reduced in haemodialysis patients: is there association with hyperhomocysteinemia and/or oxidative stress?
Garcia SC; Wyse AT; Valentini J; Roehrs M; Moro AM; Paniz C; Schmitt G; Grotto D; Pomblum VJ
Clin Biochem; 2008 May; 41(7-8):474-9. PubMed ID: 18237553
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
